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Abstract: A novel and efficient route has been developed to afford dipyridoaze-
pine derivatives from primary amines and 3,3′-(Z)-ethene-1,2-diylbis(4-chloro-
pyridine). The procedure based on a double nucleophilic aromatic substitution 
provides a valuable synthetic tool for the synthesis of dipyridoazepines. The 
reaction proceeds without catalyst, under microwave irradiation conditions. 
Keywords: azepines; heterocycles; nucleophilic aromatic substitution; trans-
ition metal-free conditions; microwave irradiation. 
INTRODUCTION 
Iminostilbene (5H-dibenz[b,f]azepine, 1) is tricyclic heterocycle (Fig. 1). 
Derivatives of this scaffold have been reported to exhibit various biological 
activities, including antioxidant1 and anticancer activity.2 5H-Dibenz[b,f]azepine 
is important structural element for the registered anticonvulsant drug carbamaze-
pine (2)3 and the tricyclic antidepressant (TCA) opipramol (3).4 Strong interest in 
the synthesis of 5H-dibenz[b,f]azepine derivatives still exists as well as their 
applications in medicinal chemistry.5 Methods based on the double N-arylation 
reaction of primary amines are of great significance since they provide a route to 
a variety of N-substituted iminostilbenes.6 
 
Fig. 1. Iminostilbene and tricyclic 5H-dibenz[b,f]azepine drugs. 
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Recently, an efficient synthetic procedure for the synthesis of 5H-dipyrido-
[4,3-b:3′,4′-f]azepine compounds via a double palladium-catalyzed amination–
cyclization reaction (Scheme 1) was disclosed.7 The synthesized compounds 
were found to exhibit interesting in vitro antibacterial activities.8 
 
Scheme 1. Pd-catalyzed synthesis of 5H-dipyrido[4,3-b:3′,4′-f]azepine compounds. 
The electron-deficient nature of γ-halopyridines enables the reaction with 
different nucleophiles in a nucleophilic aromatic substitution reaction (SNAr) via 
an addition–elimination mechanism. The displacement of chloride from 4-chloro-
pyridine by primary amines has been well studied and shown to be an efficient 
approach for the synthesis of 4-(alkylamino)pyridine derivatives. However, high 
temperatures and prolonged reaction times are usually required.9  
In continuation of ongoing studies of biologically active tricyclic hetero-
cycles,7,8,10 herein the synthesis of 5H-dipyrido[4,3-b:3′,4′-f]azepines using the 
double SNAr reaction of 3,3′-(Z)-ethene-1,2-diylbis(4-chloropyridine) with pri-
mary aliphatic amines under microwave irradiation is reported.  
EXPERIMENTAL 
Instrumentation 
Microwave reactions were performed in a Biotage Initiator 2.5 microwave reactor. The 
IR spectra were recorded on a Perkin–Elmer FTIR 1725X spectrophotometer. The NMR 
spectra were recorded on a Bruker Ultrashield Avance III spectrometer (500 MHz) using TMS 
as the internal standard. The chemical shifts are expressed in ppm (δ) values and coupling 
constants (J) in Hz. The ESI–MS (HRMS) spectra were acquired on an Agilent Technologies 
1200 Series instrument equipped with a Zorbax Eclipse Plus C18 column and a DAD detector 
in combination with a 6210 time-of-flight LC/MS instrument operated in the positive ion 
mode. The samples were dissolved in MeOH. Thin-layer chromatography was performed on 
pre-coated Merck silica gel 60 F254 and Merck RP-18 F254 plates. The solution MeOH 
(NH3) stands for a combination MeOH/NH3 (aq.) in 9:1 volume ratio. 
Chemistry 
General procedure for azepine synthesis. A reaction tube, containing a stirring bar, was 
charged with 3,3′-(Z)-ethene-1,2-diylbis(4-chloropyridine), N-methylpyrrolidone (NMP) and 
amine (10 equiv.), and capped. After pre-stirring at room temperature for 2 min, the reaction 
mixture was heated to 150 °C and stirred at same temperature for 3 h under microwave 
conditions. The products were purified by preparative column chromatography: SiO2, 
CH2Cl2/MeOH(NH3) = 9:1. 
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N,N-Dimethyl-5H-dipyrido[4,3-b:3′,4′-f]azepine-5-propanamine (5).7 Following the 
general procedure, a mixture of 3,3′-(Z)-ethene-1,2-diylbis(4-chloropyridine) (20 mg, 0.080 
mmol), N,N-dimethylpropane-1,3-diamine (100 μL, 0.80 mmol), and N-methyl-2-pyrrolidone 
(0.5 mL) was stirred at 150 °C for 24 h or for 3 h under microwave conditions. Yield: 14 mg, 
61 %. 
5-[3-(Morpholin-4-yl)propyl]-5H-dipyrido[4,3-b:3′,4′-f]azepine (6).7 Following the gen-
eral procedure, a mixture of 3,3′-(Z)-ethene-1,2-diylbis(4-chloropyridine) (20 mg, 0.080 
mmol), N-(3-aminopropyl)morpholine (90 μL, 0.80 mmol), and N-methyl-2-pyrrolidone (0.5 mL) 
was stirred at 150 °C for 24 h or for 3 h under microwave conditions. Yield: 16 mg, 62 %. 
N,N-Dimethyl-5H-dipyrido[4,3-b:3′,4′-f]azepine-5-ethanamine (7). Following the gen-
eral procedure, a mixture of 3,3′-(Z)-ethene-1,2-diylbis(4-chloropyridine) (20 mg, 0.080 
mmol), N,N-dimethylethane-1,2-diamine (75 μL, 0.80 mmol), and N-methyl-2-pyrrolidone 
(0.5 mL) was stirred at 150 °C for 24 h or for 3 h under microwave conditions. Yield: 12 mg, 
56 %. 
5H-Dipyrido[4,3-b:3′,4′-f]azepine-5-propanol (8). Following the general procedure, a 
mixture of 3,3′-(Z)-ethene-1,2-diylbis(4-chloropyridine) (20 mg, 0.080 mmol), 3-(dimethyl-
amino)propan-1-ol (60 μL, 0.80 mmol), and N-methyl-2-pyrrolidone (0.5 mL) was stirred at 
150 °C for 24 h or for 3 h under microwave conditions. Yield: 9 mg, 45 %. 
The characterization data for compounds 5–8 are given in the Supplementary material to 
this paper. 
RESULTS AND DISCUSSION 
Chemistry 
The previously reported method7 for the synthesis of N,N-dimethyl-5H- 
-dipyrido[4,3-b:3′,4′-f]azepine-5-propanamine (5) (Scheme 1, Table I, entry 1) is 
simple and efficient. Nevertheless, the use of palladium as a catalyst makes it an 
expensive procedure. In order to simplify and to re-examine the reaction 
mechanism, an experiment was performed that focused on Pd-free conditions. In 
the absence of Pd(OAc)2, ligand and base, the reaction of stilbene 4 and N,N- 
-dimethylpropane-1,3-diamine in PhMe did not occur at 100 °C (Table I, entry 
2), which strongly supported the earlier conclusion7 that palladium really is 
needed for the formation of the product. Next, an attempt was made to optimize 
the reaction of stilbene 4 with N,N-dimethylpropane-1,3-diamine under SNAr 
reaction conditions in order to define the reaction parameters that could possibly 
result in comparable yield to that given by the Pd-catalyzed method. Since the 
SNAr reaction of 4-chloropyridine and primary amines is often performed at 
elevated temperatures, toluene was replaced with N-methylpyrrolidone (NMP), a 
solvent with a higher boiling point. When the reaction temperature was elevated 
to 150 °C, the azepine 5 was obtained in moderate yield (Table I, entry 4). The 
same reaction in NMP at 100 °C did not occur thus confirming that elevated tem-
peratures are necessary for the formation of the desired product (Table I, entry 3). 
Finally, microwave irradiation was applied in order to shorten the reaction time. 
Performing the reaction in a microwave reactor for 3 h at 150 °C, resulted in 
azepine 5 in 61 % yield (Table I, entry 5). 
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Table I. Synthesis of 5 under various conditions 
Entry Solvent t / °C Pd-catalyzed MW Time, h Yield, % 
1a PhMe 100 + – 24 87 
2b PhMe 100 – – 24 0 
3b NMP 100 – – 24 0 
4b NMP 150 – – 24 58 
5b NMP 150 – + 3 61 
aPd(OAc)2 (5 mol %), JohnPhos (10 mol %), amine (3 equiv), NaOt-Bu (2.8 equiv); b10 equiv. of amine 
The same reaction conditions were then applied for the synthesis of one 
known and two new azepine derivatives (6–8, respectively; Scheme 2).  
 
Scheme 2. Synthesis of azepine derivatives. 
CONCLUSIONS 
In conclusion, the first microwave-assisted synthetic procedure for the form-
ation of 5H-dipyrido[4,3-b:3′,4′-f]azepines based on the double SNAr reaction of 
3,3′-(Z)-ethene-1,2-diylbis(4-chloropyridine) with primary aliphatic amines has 
been reported. This novel methodology was successfully applied for the synthesis 
of new azepine derivatives. Although the yields were lower than in the previ-
ously reported Pd-catalyzed method, this procedure has the great advantage of 
being transition metal-free, and the time of the reaction was significantly short-
ened by microwave heating. The next step in the development of methodology 
will be the replacement of NMP with less toxic solvent, towards a green proce-
dure for the synthesis of azepines. 
SUPPLEMENTARY MATERIAL 
The characterization data for compounds 5–8 are available electronically electronically 
at the pages of journal website: http://www.shd.org.rs/JSCS/, or from the corresponding 
author on request. 
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И З В О Д  
СИНТЕЗА АЗЕПИНА НУКЛЕОФИЛНОМ АРОМАТИЧНОМ СУПСТИТУЦИЈОМ У 
МИКРОТАЛАСНИМ РЕАКЦИОНИМ УСЛОВИМА 
НИНА БОЖИНОВИЋ, БОГДАН А. ШОЛАЈА и ИГОР М. ОПСЕНИЦА 
Хемијски факултет, Универзитет у Београду, Студентски трг 16, п. пр. 51, 11158 Београд 
Развијена је нова метода за синтезу дипиридоазепинских једињења. Азепински прс-
тен формиран је реакцијом двоструке нуклеофилне ароматичне супституције, реакци-
јом примарног амина и одговарајућег стилбена. Предност нове методе, у односу на ра-
није описане синтезе азепина, јесте ефикасна синтеза без присуствa катализатора на 
бази прелазних метала. Додатно, реакционо време значајно је смањено применом мик-
роталасних реакционих услова. 
(Примљено 24. августа, ревидирано 30. августа, прихваћено 30. августа 2016) 
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